The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?
Open accessAbstract
Purpose: To investigate the effect of intraepithelial tumor-infiltrating lymphocytes (ieTIL) and their ligands expressed by cervical tumor cells on the outcome of cervical cancer patients. Experimental Design: The prognostic value of ieTILs was investigated in 115 cases of cervical cancer. T-cell subsets, CD57+ cells, and regulatory T cells (Treg) were enumerated. The associations of these different ieTIL subtypes with human leukocyte antigen (HLA) class I and MHC class I chain-related molecule A (MICA) expression were determined in relation to clinical variables and patient survival. Results: Survival analysis showed that a high number of intraepithelial Treg (FoxP3+), a low CD8+/regulatory T-cell ratio, and a weak HLA-A expression were all associated with worse survival (P = 0.034, 0.025, and 0.033, respectively, log-rank test). Further stratification of patient groups based on HLA-A-MICA expression and HLA-A-MICA-CD8+/Treg ratio revealed an even poorer survival (P = 0.005). In a multivariate Cox analysis, low CD8+/Treg ratio (P = 0.047), weak HLA-A-MICA expression (P = 0.003), and weak HLA-A-MICA expression combined with low CD8+/Treg ratio (P = 0.002) were all found to be independent unfavorable prognostic predictors in cervical carcinoma (hazard ratios, 2.7, 4.0, and 4.9, respectively). Conclusion: Weak HLA-A-MICA expression combined with low CD8+/Treg ratio reveals a patient group with the poorest survival in cervical cancer. As a single variable, low CD8+/Treg ratio was a significant independent unfavorable prognostic factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have reported that the number and functional orientation of tumor-infiltrating CD4+ and CD8+ T cells and the presence of M1 type macrophages strongly correlates with survival in patients with CC after CRT23,24.”
From Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation (2021) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Sato, E., Olson, S. H., Ahn, J., Bundy, B. N., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C. B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,445
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D. I., & Sotomayor, E. M. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,747
Davé, S. S., Wright, G. W., Tan, B. K., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041869 · Cited by 1,417
Chapter 2: The burden of HPV-related cancers
Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,391
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature reviews. Immunology · doi:10.1038/nri1199 · Cited by 1,351
The natural history of cervical HPV infection: unresolved issues
Woodman, C. B. J., Collins, S. I., & Young, L. S. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2050 · Cited by 1,056
Hiraoka, K., Miyamoto, M., Cho, Y., Suzuoki, M., Oshikiri, T., Nakakubo, Y., Itoh, T., Ohbuchi, T., Kondo, S., & Katoh, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602934 · Cited by 480
Piersma, S. J., Jordanova, E. S., van Poelgeest, M. I. E., Kwappenberg, K. M. C., van der Hulst, J. M., Drijfhout, J. W., Melief, C. J. M., Kenter, G. G., Fleuren, G. J., Offringa, R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3388 · Cited by 414
Self-citationHuman trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule.
Ellis, S. A., Palmer, M. S., & McMichael, A. J. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.731 · Cited by 390
Tumor-infiltrating T lymphocytes: Friends or foes?
Yu, P., & Fu, Y.-X. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700389 · Cited by 299
Diederichsen, A. C. P., Hjelmborg, J., Christensen, P. B., Zeuthen, J., & Fenger, C. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0388-5 · Cited by 237
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
Menon, A. G., Rhijn, C. M. J., Morreau, H., Putter, H., Tollenaar, R. A. �. �., van de Velde, C. J. �., Fleuren, G. J., & Kuppen, P. J. K. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700055 · Cited by 216
Self-citationMehta, A., Jordanova, E. S., Kenter, G. G., Ferrone, S., & Fleuren, G. J. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0362-8 · Cited by 193
Self-citationInfiltration of cervical cancer tissue with human papilloma virus-specific cytotoxic T-lymphocytes
Evans, E. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)88693-2 · Cited by 193
Watson, N. F., Spendlove, I., Madjd, Z., McGilvray, R. W., Green, A. R., Ellis, I. O., Scholefield, J. H., & Durrant, L. G. (2005) · International Journal of Cancer · doi:10.1002/ijc.21510 · Cited by 166
Self-citationSelective cytotoxic T-lymphocyte targeting of tumor immune escape variants
van Hall, T., Wolpert, E. Z., van Veelen, P. A., Laban, S., van der Veer, M., Roseboom, M., Bres-Vloemans, S. A., Grufman, P., de Ru, A., Meiring, H. D., et al. (2006) · Nature Medicine · doi:10.1038/nm1381 · Cited by 160
MHC Class I Antigens and Immune Surveillance in Transformed Cells
Aptsiauri, N., Cabrera, T., Garcia‐Lora, A., Lopez‐Nevot, M. A., Ruiz‐Cabello, F., & Garrido, F. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(07)56005-5 · Cited by 145
Natural killer cells infiltrating colorectal cancer and MHC class I expression
Sandel, M. H., Speetjens, F. M., Menon, A. G., Albertsson, P., Basse, P. H., Hokland, M., Nagelkerke, J. F., Tollenaar, R. A. E. M., van de Velde, C. J. �., & Kuppen, P. J. K. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.039 · Cited by 112
Infiltration of cervical cancer tissue with human papilloma virus-specific cytotoxic T-lymphocytes
Evans, E. M. L., Man, S., Evans, A. S., et al. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)88864-5 · Cited by 91
Bethwaite, P. B., Holloway, L., Thornton, A., & Delahunt, B. (1996) · Pathology · doi:10.1080/00313029600169274 · Cited by 82
Isolation and characterization of tumor‐infiltrating lymphocytes from cervical carcinoma
Hilders, C. G. J. M., Ras, L., van Eendenburg, J. D. H., Nooyen, Y., & Fleuren, G. J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570608 · Cited by 67
Self-citationRuiter, D. J., Ferrier, C. M., van Muijen, G. N. P., Henzen-Logmans, S. C., Kennedy, S., Kramer, M. D., Nielsen, B. S., & Schmitt, M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00151-8 · Cited by 65
Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
Hilders, C. G. J. M., Houbiers, J. G. A., Claasen, H. H. V. R., Veldhuizen, R. W., & Fleuren, G. J. (1993) · PubMed · Cited by 63
Self-citationPrognostic relevance of TGF‐β1 and PAI‐1 in cervical cancer
Hazelbag, S., Kenter, G. G., Gorter, A., & Fleuren, G. J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20512 · Cited by 62
Self-citationBontkes, H. J., de Gruijl, T. D., Walboomers, J. M. M., van den Muysenberg, A., Gunther, A., Scheper, R. J., Meijer, C. J. L. M., & Kummer, J. A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.560 · Cited by 59
The Expression of Histocompatibility-related Leukocyte Antigens in the Pathway to Cervical Carcinoma
Hilders, C. G. J. M., Houbiers, J. G. A., Krul, E. J. T., & Fleuren, G. J. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/101.1.5 · Cited by 57
Self-citationCharaciejus, D., Pašukonienė, V., Kazlauskaitė, N., Valuckas, K. P., Petraitis, T., Mauricas, M., & Otter, W. D. (2002) · PubMed · Cited by 53
Hilders, C. G. J. M., Munoz, I. M., Nooyen, Y., & Fleuren, G. J. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1156 · Cited by 50
Self-citationHellebrekers, Zwinderman, Kenter, Peters, Snijders-Keilholz, Graziosi, Fleuren, & Trimbos (1999) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.1999.99023.x · Cited by 42
Donskov, F. N., Bennedsgaard, K. M., Hokland, M., Marcussen, N., Fisker, R. V., Madsen, H. H. T., Fode, K., & von der Maase, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0525-9 · Cited by 42
Höhn, H., Pilch, H., Günzel, S., Neukirch, C., Freitag, K., Necker, A., & Maeurer, M. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6632-6636.2000 · Cited by 38
Chao, H. T., Wang, P. H., Tseng, J. Y., Lai, C. R., Chiang, S. C., & Yuan, C. C. (1999) · PubMed · Cited by 37
Association of Allele-Specific HLA Expression and Histopathologic Progression of Cervical Carcinoma
van Driel, W. J., Tjiong, M. Y., Hilders, C. G. J. M., Trimbos, B. J. B. M. Z., & Fleuren, G. J. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0186 · Cited by 37
Self-citationNouri, A. M. E., Hussain, R. F., Oliver, R. T. D., Handy, A. M., Bartkova, I., & Bodmer, J. G. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90545-q · Cited by 34
Chan, D. P. C., Cheung, T., Tam, A. O. Y., Cheung, J. L. K., Yim, S. F., Lo, K. W. K., Siu, N. S. S., Zhou, D. X. M., & Chan, P. K. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/497342 · Cited by 33
Santin, A. D., Bellone, S., Palmieri, M., Bossini, B., Roman, J. J., Cannon, M. J., Bignotti, E., Canè, S., & Pecorelli, S. L. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00083-0 · Cited by 28
Psychosocial factors and the course of cervical intra-epithelial neoplasia: A prospective study
Tiersma, E. S. M., van der Lee, M. L., Garssen, B., Peters, A. A. W., Visser, A. P., Fleuren, G. J., van Leeuwen, K. M., le Cessie, S., & Goodkin, K. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.03.003 · Cited by 25
Self-citationFocosi, D., & Petrini, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2251 · Cited by 24
HLA Alleles and Risk of Cervical Intraepithelial Neoplasia Among Southwestern American Indian Women
Schiff, M. A., Apple, R. J., Lin, P. W., Nelson, J. L., Wheeler, C. M., & Becker, T. M. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.09.002 · Cited by 21
Psychosocial factors and the grade of cervical intra-epithelial neoplasia: a semi-prospective study
Tiersma, E. S. M., van der Lee, M. L., Peters, A. A. W., Visser, A. P., Fleuren, G. J., Garssen, B., van Leeuwen, K. M., le Cessie, S., & Goodkin, K. (2003) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.10.046 · Cited by 20
Self-citationvan Vlierberghe, R. L. P., Sandel, M. H., Prins, F. A., Iersel, L. V., van de Velde, C. J. �., Tollenaar, R. A. �. �., & Kuppen, P. J. K. (2005) · Microscopy Research and Technique · doi:10.1002/jemt.20181 · Cited by 15
Self-citationDean, J., McCarthy, D., Lawler, M., Doherty, D. G., O’Farrelly, C., & Golden‐Mason, L. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.08.017 · Cited by 13
Cited by
Sorted by citations
Gooden, M. J. M., de Bock, G. H., Leffers, N., Daemen, T., & Nijman, H. W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.189 · Cited by 1,296
Tumour-associated neutrophils in patients with cancer
Shaul, M. E., & Fridlender, Z. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0222-4 · Cited by 1,067
Shang, B., Liu, Y., Jiang, S.-J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep15179 · Cited by 985
Tumor-infiltrating lymphocytes in the immunotherapy era
Paijens, S. T., Vledder, A., de Bruyn, M., & Nijman, H. W. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00565-9 · Cited by 914
Speiser, D. E., Chijioke, O., Schaeuble, K., & Münz, C. (2023) · Nature Cancer · doi:10.1038/s43018-023-00521-2 · Cited by 514
Metadata
- Authors
- Jordanova, E. S., Gorter, A., Ayachi, O., Prins, F., Durrant, L. G., Kenter, G. G., van der Burg, S. H., & Fleuren, G. J.
- Affiliations
- Leiden University Medical Center (NL)
- Leiden University (NL)
- University of Nottingham (GB)
- 2Gynecology, and
- 3Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands and
- Venue
- Clinical Cancer Research
- Published
- 2008-04-01
- Volume
- 14
- Issue
- 7
- Pages
- 2028-2035
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2127740243
- Cited by
- 233
- References
- 44
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 8 · 2023: 10 · 2022: 15 · 2021: 14 · 2020: 15 · 2019: 17 · 2018: 12 · 2017: 10 · 2016: 12 · 2015: 17 · 2014: 11 · 2013: 11 · 2012: 18
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- cervical cancer, tumor-infiltrating lymphocytes, regulatory T cells, CD8/Treg ratio, HLA-A, mica, prognostic factors, patient survival, Foxp3, CD57, tumor immune microenvironment
- MeSH terms
- Adult, Aged, Aged, 80 and over, Uterine Cervical Neoplasms, Female, Fluorescent Antibody Technique, Humans, Middle Aged, Prognosis, Biomarkers, Tumor, HLA-A Antigens, Histocompatibility Antigens Class I, Polymerase Chain Reaction, Lymphocytes, Tumor-Infiltrating, CD8-Positive T-Lymphocytes, T-Lymphocytes, Regulatory, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
